[Syndrome of extrahepatic portal hypertension and chronic abdominal ischemia in patient with subleukemic myelosis and congenital immunodeficiency].
The article demonstrates objective difficulties and subjective mistakes in assessment of a clinical picture in a patient with subleukemic myelosis and thrombosis of the portal system. A careful examination of such patients is necessary to reveal latent disorders (in this case--a complete selective IgA deficiency) influencing treatment policy.
Lukina
E A
EA
Sysoeva
E P
EP
Kitsenko
E A
EA
Varlamova
E Iu
EIu
Inozemtseva
M V
MV
Semenova
E A
EA
Nadinskaia
M Iu
MIu
Ivashkin
V T
VT
D000005:Abdomen / Q000098:blood supply*; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use; D006975:Hypertension, Portal / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D017098:IgA Deficiency / Q000150:complications / Q000151:congenital / Q000175:diagnosis*; D007511:Ischemia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D055728:Primary Myelofibrosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D013577:Syndrome; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy
D000925:Anticoagulants; D000970:Antineoplastic Agents; D006918:Hydroxyurea